Header Logo

Connection

Ann Moormann to Herpesvirus 4, Human

Back to Details
This is a "connection" page, showing publications Ann Moormann has written about Herpesvirus 4, Human.
Ann Moormann
Connection Strength
7.203
Herpesvirus 4, Human
  1. Torgbor C, Thorley-Lawson DA, Moormann AM. Epstein-Barr virus-infected tonsillar marginal zone B cells in vivo as a precursor for immunosuppression-related B-cell lymphoma. J Virol. 2025 Aug 19; 99(8):e0105124.
    View in: PubMed
    Score: 0.845
  2. Kaymaz Y, Oduor CI, Aydemir O, Luftig MA, Otieno JA, Ong'echa JM, Bailey JA, Moormann AM. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma. J Virol. 2020 08 17; 94(17).
    View in: PubMed
    Score: 0.602
  3. Parsons E, Otieno JA, Ong'echa JM, Nixon CE, Vulule J, M?nz C, Stewart VA, Moormann AM. Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study. PLoS One. 2016; 11(12):e0167841.
    View in: PubMed
    Score: 0.468
  4. Matar CG, Jacobs NT, Speck SH, Lamb TJ, Moormann AM. Does EBV alter the pathogenesis of malaria? Parasite Immunol. 2015 Sep; 37(9):433-45.
    View in: PubMed
    Score: 0.427
  5. Rochford R, Moormann AM. Burkitt's Lymphoma. Curr Top Microbiol Immunol. 2015; 390(Pt 1):267-85.
    View in: PubMed
    Score: 0.408
  6. Oduor CI, Chelimo K, Ouma C, Mulama DH, Foley J, Vulule J, Bailey JA, Moormann AM. Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma. Am J Trop Med Hyg. 2014 Sep; 91(3):649-54.
    View in: PubMed
    Score: 0.396
  7. Mulama DH, Bailey JA, Foley J, Chelimo K, Ouma C, Jura WG, Otieno J, Vulule J, Moormann AM. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer. 2014 Feb 01; 134(3):645-53.
    View in: PubMed
    Score: 0.370
  8. Snider CJ, Cole SR, Chelimo K, Sumba PO, Macdonald PD, John CC, Meshnick SR, Moormann AM. Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens. PLoS One. 2012; 7(3):e31753.
    View in: PubMed
    Score: 0.336
  9. Moormann AM, Snider CJ, Chelimo K. The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis. 2011 Oct; 24(5):435-41.
    View in: PubMed
    Score: 0.325
  10. M?nz C, Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol. 2008 Dec; 18(6):381-7.
    View in: PubMed
    Score: 0.265
  11. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, Kazura JW. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis. 2007 Mar 15; 195(6):799-808.
    View in: PubMed
    Score: 0.236
  12. Kim IE, Fola AA, Puig E, Maina TK, Hui ST, Ma H, Zuckerman K, Agwati EO, Leonetti A, Crudale R, Luftig MA, Moormann AM, Oduor C, Bailey JA. Comparison of nanopore with illumina whole genome assemblies of the Epstein-Barr virus in Burkitt lymphoma. Sci Rep. 2025 Mar 31; 15(1):10970.
    View in: PubMed
    Score: 0.207
  13. Moormann AM, Chelimo K, Sumba OP, Lutzke ML, Ploutz-Snyder R, Newton D, Kazura J, Rochford R. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis. 2005 Apr 15; 191(8):1233-8.
    View in: PubMed
    Score: 0.206
  14. Kim IE, Oduor C, Stamp J, Luftig MA, Moormann AM, Crawford L, Bailey JA. Incorporation of Epstein-Barr viral variation implicates significance of Latent Membrane Protein 1 in survival prediction and prognostic subgrouping in Burkitt lymphoma. Int J Cancer. 2025 Jun 01; 156(11):2188-2199.
    View in: PubMed
    Score: 0.206
  15. Rochford R, Cannon MJ, Moormann AM. Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol. 2005 02; 3(2):182-7.
    View in: PubMed
    Score: 0.205
  16. Willard KA, Barry AP, Oduor CI, Ong'echa JM, Bailey JA, Moormann AM, Luftig MA. Viral and host factors drive a type 1 Epstein-Barr virus spontaneous lytic phenotype. mBio. 2023 Dec 19; 14(6):e0220423.
    View in: PubMed
    Score: 0.188
  17. Oluoch PO, Forconi CS, Oduor CI, Ritacco DA, Akala HM, Bailey JA, Juliano JJ, Ong'echa JM, M?nz C, Moormann AM. Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute Plasmodium falciparum Malaria Episodes. Int J Mol Sci. 2023 Apr 04; 24(7).
    View in: PubMed
    Score: 0.181
  18. Saikumar Lakshmi P, Oduor CI, Forconi CS, M'Bana V, Bly C, Gerstein RM, Otieno JA, Ong'echa JM, M?nz C, Luftig MA, Brehm MA, Bailey JA, Moormann AM. Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies. Life Sci Alliance. 2023 05; 6(5).
    View in: PubMed
    Score: 0.180
  19. Movassagh M, Oduor C, Forconi C, Moormann AM, Bailey JA. Sensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia. Sci Rep. 2019 12 30; 9(1):20321.
    View in: PubMed
    Score: 0.144
  20. Kaymaz Y, Oduor CI, Yu H, Otieno JA, Ong'echa JM, Moormann AM, Bailey JA. Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences. Mol Cancer Res. 2017 05; 15(5):563-576.
    View in: PubMed
    Score: 0.120
  21. Reynaldi A, Schlub TE, Piriou E, Ogolla S, Sumba OP, Moormann AM, Rochford R, Davenport MP. Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection. J Infect Dis. 2016 Nov 01; 214(9):1390-1398.
    View in: PubMed
    Score: 0.114
  22. Reynaldi A, Schlub TE, Chelimo K, Sumba PO, Piriou E, Ogolla S, Moormann AM, Rochford R, Davenport MP. Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children. J Infect Dis. 2016 Mar 15; 213(6):985-91.
    View in: PubMed
    Score: 0.108
  23. Chattopadhyay PK, Chelimo K, Embury PB, Mulama DH, Sumba PO, Gostick E, Ladell K, Brodie TM, Vulule J, Roederer M, Moormann AM, Price DA. Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation. J Virol. 2013 Feb; 87(3):1779-88.
    View in: PubMed
    Score: 0.088
  24. Piriou E, Asito AS, Sumba PO, Fiore N, Middeldorp JM, Moormann AM, Ploutz-Snyder R, Rochford R. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis. 2012 Mar 15; 205(6):906-13.
    View in: PubMed
    Score: 0.083
  25. Sumba PO, Kabiru EW, Namuyenga E, Fiore N, Otieno RO, Moormann AM, Orago AS, Rosenbaum PF, Rochford R. Microgeographic variations in Burkitt's lymphoma incidence correlate with differences in malnutrition, malaria and Epstein-Barr virus. Br J Cancer. 2010 Nov 23; 103(11):1736-41.
    View in: PubMed
    Score: 0.077
  26. Piriou E, Kimmel R, Chelimo K, Middeldorp JM, Odada PS, Ploutz-Snyder R, Moormann AM, Rochford R. Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol. 2009 Jun; 81(6):1088-93.
    View in: PubMed
    Score: 0.069
  27. Moormann AM, Lozada JS. Burkitt lymphoma in Uganda: 50 years of ongoing discovery. Pediatr Blood Cancer. 2009 Apr; 52(4):433-4.
    View in: PubMed
    Score: 0.068
  28. Moormann AM, Heller KN, Chelimo K, Embury P, Ploutz-Snyder R, Otieno JA, Oduor M, M?nz C, Rochford R. Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses. Int J Cancer. 2009 Apr 01; 124(7):1721-6.
    View in: PubMed
    Score: 0.068
  29. Muriuki BM, Forconi CS, Kirwa EK, Maina TK, Ariera BO, Bailey JA, Ghansah A, Moormann AM, Ong'echa JM. Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma. PLoS One. 2023; 18(8):e0275046.
    View in: PubMed
    Score: 0.046
  30. MacNeil A, Sumba OP, Lutzke ML, Moormann A, Rochford R. Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br J Cancer. 2003 May 19; 88(10):1566-9.
    View in: PubMed
    Score: 0.046
  31. Agwati EO, Oduor CI, Ayieko C, Ong'echa JM, Moormann AM, Bailey JA. Profiling genome-wide recombination in Epstein Barr virus reveals type-specific patterns and associations with endemic-Burkitt lymphoma. Virol J. 2022 12 08; 19(1):208.
    View in: PubMed
    Score: 0.044
  32. Muriuki BM, Forconi CS, Oluoch PO, Bailey JA, Ghansah A, Moormann AM, Ong'echa JM. Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children. Sci Rep. 2021 05 31; 11(1):11343.
    View in: PubMed
    Score: 0.040
  33. Quintana MDP, Smith-Togobo C, Moormann A, Hviid L. Endemic Burkitt lymphoma - an aggressive childhood cancer linked to Plasmodium falciparum exposure, but not to exposure to other malaria parasites. APMIS. 2020 Feb; 128(2):129-135.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.